Keyphrases
Recombinant
100%
Adoptive Immunotherapy
100%
Human Cancer
100%
Lymphokine-activated Killer Cells
100%
Recombinant interleukin-2
100%
Human interleukin-2
100%
Peripheral Blood Mononuclear Cells
28%
Cancer Patients
28%
Tumor Regression
28%
High Dose
14%
Cell Function
14%
Cell Infusion
14%
Induced Activation
14%
Peripheral Blood Cells
14%
Interleukin-2
14%
Reperfusion
14%
Reduced Toxicity
14%
Cell Culture Model
14%
Activated Cells
14%
Adoptive Transfer
14%
Effector Cells
14%
Consecutive Days
14%
Leukapheresis
14%
Murine Tumor Model
14%
Tumor-bearing Mice
14%
Culture Flask
14%
Prolonged Administration
14%
Conventional Cancer Therapy
14%
Conventional Culture
14%
Culture Bag
14%
Alternative Regimens
14%
Medicine and Dentistry
Malignant Neoplasm
100%
Low Drug Dose
100%
Interleukin 2
100%
Adoptive Immunotherapy
100%
Lymphokine Activated Killer Cell
100%
Recombinant Interleukin 2
100%
Infusion
25%
Tumor Regression
25%
Cancer Therapy
12%
Neoplasm
12%
Drug Megadose
12%
Cell Function
12%
Cell Culture
12%
Tumor Model
12%
Peripheral Blood Mononuclear Cell
12%
Effector Cell
12%
Blood Cell
12%
Leukapheresis
12%
Adoptive Transfer
12%
Immunology and Microbiology
Low Drug Dose
100%
Interleukin 2
100%
Adoptive Immunotherapy
100%
Lymphokine Activated Killer Cell
100%
Recombinant Interleukin 2
100%
Drug Megadose
12%
Cell Function
12%
Cell Culture
12%
Hemocyte
12%
Effector Cell
12%
Leukapheresis
12%
Peripheral Blood Mononuclear Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Immunotherapy
100%
Interleukin 2
100%
Lymphokine
100%
Recombinant Interleukin 2
100%
Tumor Regression
25%
Neoplasm
12%
Cell Culture
12%
Tumor Model
12%
Biochemistry, Genetics and Molecular Biology
Low Drug Dose
100%
Interleukin 2
100%
Lymphokine
100%
Cell Function
11%
Peripheral Blood Mononuclear Cell
11%
Drug Megadose
11%
Cell Culture
11%
Peripheral Blood Cell
11%
Leukapheresis
11%
Engineering
Human Cancer
100%
Peripheral Blood
100%
Activated Cell
66%
Periodic Time
33%